Pacira BioSciences Inc
Pacira BioSciences Inc (PCRX) Wheel Strategy
PCRX wheel strategy scan found 7 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 86.3%.
Read more
Running a PCRX wheel strategy lets you generate consistent premium income on Pacira BioSciences Inc while setting your own entry and exit prices on the underlying. Pacira BioSciences Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own PCRX, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best PCRX wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on PCRX, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable PCRX wheel from a losing one.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure.
The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the PCRX wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your PCRX wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Oct 16, 2026 | 25.00 | $0.35 | $1.30 | -0.41 | 22 | 42% | 53.6% | 86.3% | 2 |
| Feb 19, 2027 | 22.50 | $1.05 | $2.38 | -0.29 | 148 | 42% | 56.9% | 26.0% | 3 |
| Feb 19, 2027 | 20.00 | $0.35 | $1.83 | -0.21 | 148 | 42% | 68.3% | 22.5% | 0 |
| Jan 15, 2027 | 22.50 | $0.75 | $1.38 | -0.26 | 113 | 42% | 59.5% | 19.7% | 32 |
| May 21, 2027 | 22.50 | $1.50 | $2.30 | -0.28 | 239 | 42% | 52.5% | 15.6% | 0 |
| May 21, 2027 | 20.00 | $0.85 | $1.60 | -0.20 | 239 | 42% | 61.8% | 12.2% | 0 |
| May 21, 2027 | 12.50 | $0.10 | $0.68 | -0.07 | 239 | 42% | 89.4% | 8.2% | 0 |
As of September 25, 2026
Run the Wheel on PCRX With Confidence
Find the best PCRX wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→